585
Views
20
CrossRef citations to date
0
Altmetric
Pharmacoeconomic Evaluation

Pharmacoeconomic evaluation of warfarin pharmacogenomics

, PharmD BCPS
Pages 435-441 | Published online: 14 Jan 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Gillian Bartlett, Jumana Antoun & Nathalie K Zgheib. (2012) Theranostics in primary care: pharmacogenomics tests and beyond. Expert Review of Molecular Diagnostics 12:8, pages 841-855.
Read now

Articles from other publishers (19)

Daniel Felipe Silgado-Guzmán, Mariana Angulo-Aguado, Adrien Morel, María José Niño-Orrego, Daniel-Armando Ruiz-Torres, Nora Constanza Contreras Bravo, Carlos Martin Restrepo, Oscar Ortega-Recalde & Dora Janeth Fonseca-Mendoza. (2022) Characterization of ADME Gene Variation in Colombian Population by Exome Sequencing. Frontiers in Pharmacology 13.
Crossref
Kewal K. JainKewal K. Jain. 2021. Textbook of Personalized Medicine. Textbook of Personalized Medicine 701 711 .
Mohammad Javad Soltani Banavandi & Naghmeh Satarzadeh. (2020) Association between VKORC1 gene polymorphism and warfarin dose requirement and frequency of VKORC1 gene polymorphism in patients from Kerman province. The Pharmacogenomics Journal 20:4, pages 574-578.
Crossref
Siok Shen Ng, Surakit Nathisuwan, Arintaya Phrommintikul & Nathorn Chaiyakunapruk. (2020) Cost-effectiveness of warfarin care bundles and novel oral anticoagulants for stroke prevention in patients with atrial fibrillation in Thailand. Thrombosis Research 185, pages 63-71.
Crossref
Xi Li, Dan Li, Ji-Chu Wu, Zhao-Qian Liu, Hong-Hao Zhou & Ji-Ye Yin. (2019) Precision dosing of warfarin: open questions and strategies. The Pharmacogenomics Journal 19:3, pages 219-229.
Crossref
Letícia C. Tavares, Nubia E. Duarte, Leiliane R. Marcatto, Renata A. G. Soares, Jose E. Krieger, Alexandre C. Pereira & Paulo Caleb Junior Lima Santos. (2018) Impact of incorporating ABCB1 and CYP4F2 polymorphisms in a pharmacogenetics-guided warfarin dosing algorithm for the Brazilian population. European Journal of Clinical Pharmacology 74:12, pages 1555-1566.
Crossref
Letícia C Tavares, Leiliane R Marcatto & Paulo CJL Santos. (2018) Genotype-guided warfarin therapy: current status. Pharmacogenomics 19:7, pages 667-685.
Crossref
Justin B. Kaye, Lauren E. Schultz, Heidi E. Steiner, Rick A. Kittles, Larisa H. Cavallari & Jason H. Karnes. (2017) Warfarin Pharmacogenomics in Diverse Populations. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37:9, pages 1150-1163.
Crossref
D. ParkerE. J. SandersK. J. Burghardt. (2016) Pharmacogenetics of antiepileptic drugs: A brief review. Mental Health Clinician 6:1, pages 28-34.
Crossref
Daniel M. Witt, Nathan P. Clark, Scott Kaatz, Terri Schnurr & Jack E. Ansell. (2016) Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism. Journal of Thrombosis and Thrombolysis 41:1, pages 187-205.
Crossref
Kewal K. JainKewal K. Jain. 2015. Textbook of Personalized Medicine. Textbook of Personalized Medicine 681 692 .
Huey Yi Chong, Surasak Saokaew, Kuntika Dumrongprat, Unchalee Permsuwan, David Bin-Chia Wu, Piyamitr Sritara & Nathorn Chaiyakunapruk. (2014) Cost-effectiveness analysis of pharmacogenetic-guided warfarin dosing in Thailand. Thrombosis Research 134:6, pages 1278-1284.
Crossref
H. Salter & R. Holland. (2014) Biomarkers: refining diagnosis and expediting drug development - reality, aspiration and the role of open innovation. Journal of Internal Medicine 276:3, pages 215-228.
Crossref
Yanbing Zu, Min-Han Tan, Balram Chowbay, Soo Chin Lee, Huiling Yap, Ming Ta Michael Lee, Liang-Suei Lu, Chun-Ping Chang & Jackie Y. Ying. (2014) Nanoprobe-based genetic testing. Nano Today 9:2, pages 166-171.
Crossref
Yan Xu & Ana Johnson. (2013) Opioid Therapy Pharmacogenomics for Noncancer Pain: Efficacy, Adverse Events, and Costs. Pain Research and Treatment 2013, pages 1-8.
Crossref
Paulo Caleb Junior Lima Santos, Carla Luana Dinardo, Isolmar Tadeu Schettert, Renata Alonso Gadi Soares, Liz Kawabata-Yoshihara, Isabela Martins Bensenor, José Eduardo Krieger, Paulo Andrade Lotufo & Alexandre Costa Pereira. (2012) CYP2C9 and VKORC1 polymorphisms influence warfarin dose variability in patients on long-term anticoagulation. European Journal of Clinical Pharmacology 69:4, pages 789-797.
Crossref
Renata Alonso Gadi SoaresPaulo Caleb Junior Lima SantosGeorge Luiz Lins Machado-CoelhoRaimundo Marques do NascimentoJose Geraldo MillJose Eduardo KriegerAlexandre Costa Pereira. (2012) CYP2C9 and VKORC1 Polymorphisms Are Differently Distributed in the Brazilian Population According to Self-Declared Ethnicity or Genetic Ancestry . Genetic Testing and Molecular Biomarkers 16:8, pages 957-963.
Crossref
Joyce H. S. You, Kia K. N. Tsui, Raymond S. M. Wong & Gergory Cheng. (2012) Cost-Effectiveness of Dabigatran versus Genotype-Guided Management of Warfarin Therapy for Stroke Prevention in Patients with Atrial Fibrillation. PLoS ONE 7:6, pages e39640.
Crossref
Niclas Eriksson & Mia Wadelius. (2012) Prediction of warfarin dose: why, when and how?. Pharmacogenomics 13:4, pages 429-440.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.